Novir is being recognized for its innovative spirit and first-class team.
The company won a number of awards from publications and organizations, including the top prize in Governor Evers’ 2020 Wisconsin Economic Development Corp. “We’re All Innovating” Awards. It has also been honored with a Wisconsin Innovation Award, a Metropolitan Milwaukee Association of Commcerce Focus on the Future Award, and Milwaukee Business Journal Tech Award. Prosper Jobs also included Novir on its list of “2022 Milwaukee Companies with the Best Benefits.”
Novir has a clear vision, strategy, and plan — and the people to deliver it.
The company has begun building a product innovation pipeline supported by technology, designed in response to customer feedback, and informed by its experienced team. In doing so, it will meet the testing needs of the future, allowing for inexpensive screening in the home for most indications, and to support managing access to safer settings, from campuses to workplaces to sports arenas, through its passport software.
In early 2021 and in partnership with Milwaukee-based MPE-INC, Novir began manufacturing its INSTA COVID-19 rapid antibody and antigen tests, and it has received the CE Mark allowing for the tests’ sale and use in Europe and other markets that accept and recognize the mark. Novir has begun clinical trials for both tests in advance of a submission to the Food and Drug Administration for Emergency Use Authorization in the United States.
Post-COVID, the company will build on its mission of early detection of life-threatening infections to focus on other viruses, diseases, or indications, like the flu, strep, cancer, STDs and GI infections, with testing increasingly being done in-home and with the support of telehealth providers.